Ye‐Xiong Li

10.1k total citations
283 papers, 4.5k citations indexed

About

Ye‐Xiong Li is a scholar working on Oncology, Pathology and Forensic Medicine and Surgery. According to data from OpenAlex, Ye‐Xiong Li has authored 283 papers receiving a total of 4.5k indexed citations (citations by other indexed papers that have themselves been cited), including 133 papers in Oncology, 94 papers in Pathology and Forensic Medicine and 91 papers in Surgery. Recurrent topics in Ye‐Xiong Li's work include Lymphoma Diagnosis and Treatment (62 papers), Advanced Radiotherapy Techniques (46 papers) and Breast Cancer Treatment Studies (44 papers). Ye‐Xiong Li is often cited by papers focused on Lymphoma Diagnosis and Treatment (62 papers), Advanced Radiotherapy Techniques (46 papers) and Breast Cancer Treatment Studies (44 papers). Ye‐Xiong Li collaborates with scholars based in China, United States and Switzerland. Ye‐Xiong Li's co-authors include Shulian Wang, Kuo Men, Weihu Wang, Xin-Fan Liu, Jing Jin, Yue‐Ping Liu, Zihao Yu, Jianrong Dai, Hui Fang and Junlin Yi and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Ye‐Xiong Li

258 papers receiving 4.4k citations

Peers

Ye‐Xiong Li

ONCOL

PFM

RNMI

SURGE

PRM

Chang‐Ok Suh South Korea

Shulian Wang China

Weihu Wang China

Youlia Kirova France

R. Dendale France

Samuel T. Chao United States

Kathryn Beal United States

Scott G. Soltys United States

Jean‐Marc Cosset France

Juergen Dunst Germany

Chang‐Ok Suh South Korea

Ye‐Xiong Li

1.6k ×0.8

ONCOL

1.3k ×0.7

PFM

582 ×0.6

RNMI

1.2k ×1.2

SURGE

1.3k ×1.4

PRM

Citations per year, relative to Ye‐Xiong Li Ye‐Xiong Li (= 1×) peers Chang‐Ok Suh

Countries citing papers authored by Ye‐Xiong Li

Since Specialization

Citations

This map shows the geographic impact of Ye‐Xiong Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ye‐Xiong Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ye‐Xiong Li more than expected).

Fields of papers citing papers by Ye‐Xiong Li

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ye‐Xiong Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ye‐Xiong Li. The network helps show where Ye‐Xiong Li may publish in the future.

Co-authorship network of co-authors of Ye‐Xiong Li

This figure shows the co-authorship network connecting the top 25 collaborators of Ye‐Xiong Li. A scholar is included among the top collaborators of Ye‐Xiong Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ye‐Xiong Li. Ye‐Xiong Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wang, Yu, Xu Guan, Xin Liu, et al.. (2025). Neoadjuvant immunotherapy and chemoradiotherapy for mismatch repair proficient locally advanced rectal cancer: A systematic review and meta-analysis. Radiotherapy and Oncology. 211. 111073–111073.

Wang, Shijia, Yirui Zhai, Wen‐Wen Zhang, et al.. (2024). Dosimetric benefit and clinical feasibility of deep inspiration breath-hold and volumetric modulated arc therapy-based postmastectomy radiotherapy for left-sided breast cancer. Scientific Reports. 14(1). 24638–24638.

Liu, Yang, Xin Liu, Yaqian Han, et al.. (2024). Evidence of being cured for nasopharyngeal carcinoma: results of a multicenter patient-based study in China. The Lancet Regional Health - Western Pacific. 49. 101147–101147. 2 indexed citations

Tang, Yuan, Lichun Wei, Shixin Liu, et al.. (2024). Preoperative short‐course radiotherapy followed by chemotherapy and PD‐1 inhibitor administration for locally advanced rectal cancer: A study protocol of a randomized phase II/III trial (STELLAR II study). Colorectal Disease. 26(9). 1732–1740. 2 indexed citations

Zhu, Yingming, Xin Liu, Shu‐Nan Qi, et al.. (2024). Optimizing the prognostic capacity of baseline 18F-FDG PET/CT metabolic parameters in extranodal natural killer/T-cell lymphoma by using relative and absolute thresholds. Heliyon. 10(3). e25184–e25184. 2 indexed citations

Hu, Chaosu, et al.. (2024). Optimizing Cervical Target Volume in Patients with Nasopharyngeal Cancer Based On Nodal Drainage Distance. Clinical Cancer Research. 30(9). 1801–1810. 1 indexed citations

Liu, Zhiqiang, Siye Chen, Yong-Wen Song, et al.. (2023). Voluntary Deep Inspiration Breath-Hold (VDIBH) Whole-Breast Irradiation Assisted by Optical Surface Monitoring System (OSMS) in Patients With Left-Sided Breast Cancer: A Prospective Phase II Study. Technology in Cancer Research & Treatment. 22. 2223915661–2223915661. 1 indexed citations

Tian, Yuan, Yong-Wen Song, Shulian Wang, et al.. (2023). Assessment of delivered dose in prostate cancer patients treated with ultra-hypofractionated radiotherapy on 1.5-Tesla MR-Linac. Frontiers in Oncology. 13. 1039901–1039901. 6 indexed citations

Liu, Yang, Yaqian Han, Desheng Hu, et al.. (2023). Involved site radiation therapy in stage I-III nasopharyngeal carcinoma with limited lymph node burden (ISRT-NPC) or elective region irradiation: a study protocol for a multicenter non-inferiority randomized controlled phase III clinical trial. BMC Cancer. 23(1). 724–724.

10.

Liu, Wenyang, Wen Zhang, Yuan Tang, et al.. (2023). Metastasis risk stratification and response prediction through dynamic viable circulating tumor cell counts for rectal cancer in a neoadjuvant setting. Cancer Medicine. 12(10). 11438–11450. 5 indexed citations

11.

Qi, Shunan, Chen Hu, Xin Liu, et al.. (2023). Tislelizumab and Radiation Therapy in Low-Risk Early-Stage Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type: A Phase II Study Protocol. Future Oncology. 20(5). 245–256.

12.

Zhang, Jing, Bingzhi Wang, Yu Tang, et al.. (2023). The prognostic value of tumour-infiltrating lymphocytes, programmed cell death protein-1 and programmed cell death ligand-1 in Stage I–III triple-negative breast cancer. British Journal of Cancer. 128(11). 2044–2053. 7 indexed citations

13.

Zhang, Ye, Xuesong Chen, Jingbo Wang, et al.. (2022). Sinonasal Inverted Papilloma–Associated and De Novo Squamous Cell Carcinoma: A Tale of Two Cities or Not. Cancers. 14(21). 5211–5211.

14.

Chen, Bo, Jianxiong Wu, Liming Wang, et al.. (2021). Phase 2 Study of Adjuvant Radiotherapy Following Narrow‐Margin Hepatectomy in Patients With HCC. Hepatology. 74(5). 2595–2604. 48 indexed citations

15.

Yan, Hui, Jianrong Dai, & Ye‐Xiong Li. (2018). A fast optimization approach for treatment planning of volumetric modulated arc therapy. Radiation Oncology. 13(1). 101–101. 7 indexed citations

16.

Wang, Xin, Jing Jin, Ye‐Xiong Li, et al.. (2011). Analysis of recurrence for locally advanced gastric or gastroesophageal cancer patients after receiving curative gastrectomy ( ＞ D1 ) and its indication for adjuvant chemoradiotherapy. Zhonghua fangshe zhongliuxue zazhi. 20(2). 133–137. 3 indexed citations

17.

Li, Ye‐Xiong, Hui Fang, Shunan Qi, et al.. (2009). Variable Clinical Presentations of Nasal and Waldeyer Ring Natural Killer/T-Cell Lymphoma. Clinical Cancer Research. 15(8). 2905–2912. 85 indexed citations

18.

Wang, Weihu, et al.. (2006). Radiation enhancement on fibrosarcoma cells by arsenic trioxide. Zhonghua fangshe zhongliuxue zazhi. 15(6). 448–451. 1 indexed citations

19.

Liu, Xiaojun, Ying Guo, Ye‐Xiong Li, et al.. (2005). Molecular Basis for G2 Arrest Induced by 2′- C -Cyano-2′-Deoxy-1-β- d - Arabino -Pentofuranosylcytosine and Consequences of Checkpoint Abrogation. Cancer Research. 65(15). 6874–6881. 40 indexed citations

20.

Coucke, Philippe, et al.. (1997). Cell Line Specific Radiosensitizing Effect of Zalcitabine (2',3'-dideoxycytidine). Acta Oncologica. 36(2). 199–205. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact